Revolutionary Continuous Testosterone Monitoring Technology
Velocity Diagnostic is pioneering the world's first Continuous Testosterone Monitor (CTM™) - a breakthrough biosensor patch that transforms hormone monitoring through cutting-edge technology.
About Velocity Diagnostic
Velocity Diagnostic is developing the world's first Continuous Testosterone Monitor (CTM™) - a breakthrough biosensor patch that continuously tracks free testosterone levels through minimally invasive micro-needles and proprietary electrochemical aptamer technology.
This revolutionary approach addresses critical gaps in current testosterone monitoring, providing real-time insights that enable safer, more effective hormone therapy management for millions of patients worldwide.
How CTM™ Technology Works
01
Micro-Needle Application
Minimally invasive micro-needles penetrate the skin surface to access interstitial fluid containing testosterone molecules.
02
Aptamer Detection
Proprietary electrochemical aptamer technology selectively binds to free testosterone, enabling precise real-time measurement.
03
Continuous Monitoring
The biosensor patch provides 24/7 testosterone level tracking, delivering unprecedented insights into hormone fluctuations.
04
Data Transmission
Real-time data is wirelessly transmitted to healthcare providers and patients for immediate treatment optimization.
Massive Market Opportunity
$10B+
Global Market Size
Total addressable market for testosterone monitoring and therapy solutions worldwide.
11M+
U.S. Patients
American men currently receiving testosterone replacement therapy requiring regular monitoring.
100%
Market Growth
Rising awareness of declining testosterone levels driving unprecedented demand for monitoring solutions.
Current monitoring gaps create significant safety risks and suboptimal treatment outcomes, representing a critical unmet medical need that CTM™ technology directly addresses.
Target Applications
Clinical Medicine
Testosterone replacement therapy monitoring for millions of patients requiring precise hormone level management and safety oversight.
Elite Military (DOD/SOF)
Performance optimization and health monitoring for special operations forces requiring peak physical and cognitive performance.
Professional Sports
Athletic performance monitoring and anti-doping compliance for professional athletes and sports organizations worldwide.
Unmatched Competitive Advantage
First-to-Market Solution
World's first continuous testosterone monitoring technology, establishing Velocity Diagnostic as the pioneer in this critical medical field.
Patented Aptamer Technology
Proprietary electrochemical aptamer technology enabling selective, real-time hormone detection with unprecedented accuracy and reliability.
No Current Competition
Zero competitors possess the technical capacity to address this urgent medical need, providing significant market advantage.
Platform Technology
Foundation for future multi-analyte endocrine monitoring, expanding into comprehensive hormone tracking capabilities.
Investment Thesis
"This represents a biotechnological 'gap fill' moment where novel sensor technology can meet an urgent, unaddressed global medical need."
The CTM™ serves as the "lead domino" for a comprehensive wearable endocrine monitoring platform, positioning Velocity Diagnostic at the forefront of personalized hormone therapy and digital endocrinology.
This breakthrough technology addresses a critical gap in healthcare monitoring, creating unprecedented opportunities for improved patient outcomes and market leadership.
Technology Innovation Pipeline
1
Phase 1: CTM™ Development
Complete development and validation of the world's first continuous testosterone monitoring system.
2
Phase 2: Clinical Validation
Comprehensive clinical trials demonstrating safety, efficacy, and superior patient outcomes compared to traditional monitoring.
3
Phase 3: Market Launch
Commercial deployment across clinical medicine, military applications, and professional sports markets.
4
Phase 4: Platform Expansion
Development of multi-analyte endocrine monitoring capabilities for comprehensive hormone tracking solutions.
Connect With Velocity Diagnostic
Join us in revolutionizing testosterone monitoring and personalized hormone therapy.
Partnership Opportunities
Explore collaborations to bring cutting-edge solutions to market faster.
Investment Inquiries
Learn about our vision and growth potential in the health tech sector.
Leadership Team
Direct contact with our leadership for strategic discussions.
Reach Out Today
Ryan J. Gustin
CEO & Co-Founder
All Rights Reserved. Velocity Diagnostic. 2025